Table 3.
Association of GSDME expression with the features of OSCC patients
| Characteristics | GSDME expression | P Value | |
|---|---|---|---|
|
| |||
| High (%) | Low (%) | ||
| Age | |||
| ≤40 | 12 (70.6) | 5 (29.4) | |
| >40 | 11 (47.8) | 12 (52.2) | 0.185 |
| Gender | |||
| Male | 11 (50.0) | 11 (50.0) | |
| Female | 12 (66.7) | 6 (33.3) | 0.301 |
| Differentiation | |||
| Well | 8 (50.0) | 8 (50.0) | |
| Moderate | 9 (60.0) | 6 (40.0) | |
| Poor | 6 (66.7) | 3 (33.3) | 0.414 |
| Lymphatic metastasis | |||
| No | 8 (42.1) | 11 (57.9) | |
| Yes | 15 (71.4) | 6 (28.6) | 0.063 |
| Clinical stage (T) | |||
| 1 | 8 (72.7) | 3 (27.3) | |
| 2 | 5 (38.4) | 8 (61.5) | |
| 3 | 7 (70.00) | 3 (30.00) | |
| 4 | 3 (50.00) | 3 (50.00) | 0.688 |
GSDME positive 23 (57.5%), negative 17 (42.5%).